The American Hospital Association has again blasted the drug industry’s alliance with community health centers for 340B reform, calling it “another misguided attempt by drug companies to dismantle [340B] so that they can continue to pad their billion-dollar bottom lines.”
AHA, the nation’s largest hospital trade group, last week published a blog post and related talking points about Pharmaceutical Research and Manufacturers of America and the National Association of Community Health Centers’ 10 principles to guide federal 340B legislation. PhRMA and NACHC launched their collaborative effort, called ASAP 340B, on March 9. They said they want to ensure that 340B program “benefits patients and true safety-net providers.” PhRMA and NACHC’s plan would slash disproportionate share hospital participation in 340B and cut DSH hospital access to 340B pricing.
The American Hospital Association has again blasted the drug industry’s alliance with community health centers for 340B reform, calling it “another misguided attempt by drug companies to dismantle [340B] so that they can continue to pad their billion-dollar bottom lines.” […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
